THE ROLE OF ANTIDEPRESSANTS IN CARDIOLOGY PRACTICE

Authors

  • Boltaboev Alisher Fergana Medical Institute of Public Department of Internal Medicine №1

DOI:

https://doi.org/10.51699/mjssh.v1i4.192

Keywords:

cardiovascular diseases, depression, antidepressants

Abstract

Amitriptyline was for a long time the sole medication for the management of depression in cardiological patients despite a large number of side effects. It was substituted by the safe and cardiologically neutral sertraline, a selective serotonin re-uptake inhibitor. Presently, the results of agomelatine therapy of cardiovascular diseases and accompanying depressions arise great interest

References

Krasnov V. N. Depression and cardiovascular diseases. Practitioner. doctor 2002; 2:31-32.

World Health Organization. World health report. New York; 2001.

Kononchuk N.V. On the psychological meaning of suicides. Psych. magazine 1989; 5:95-102.

Vasyuk Yu. A., Dovzhenko T. V., Shkolnik E. L., Yushchuk E. N. Depression and chronic heart failure in cardiovascular diseases. Moscow: Anacharsis ; 2006.

Vasyuk Yu. A., Dovzhenko T. V., Shkolnik E. L., Yushchuk E. N. Depressive and anxiety disorders in cardiology. 2nd ed. Moscow: Anacharsis ; 2009.

Vasyuk Yu. A., Dovzhenko T. V. Diagnosis and treatment of depression in diseases of the cardiovascular system: Proc. allowance. Moscow: Anacharsis ; 2006.

Smulevich A. B. Depression in somatic and mental diseases. M .; 2003. 211-266.

Azima H., Vispo RH Imipramine: A potent new antidepressant compound. Am. J. Psychiatry 1958; 115(3): 245-246.

Healy D. The Psychopharmacologists : Interviews. London: Chapman & Hall; 1996. 8.

Weissman MM Treatment of depression : bridging the 21st Century. Washington: American College of Chest Physicians; 2001. 10-11.

Avrutsky G. Ya., Neduva A. A. Treatment of the mentally ill. M.: Medicine; 1981.

Kukes V. G. Clinical pharmacology. 3rd. ed. Moscow: GEOTAR-Media; 2006. 729.

Roose SP, Spatz E. Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid? New York: College of Physicians and Surgeons, Columbia University; 1999; 60(9): 2674.

Braunwald's heart disease: A textbook of cardiovascular medicine / Braunwald E., Bonow RO, Mann DL et al. 7th ed. W. B. Saunders Company; 2004.

Boyer P., Guelfi JD Troubles somatiques et etats depressifs . Ann. Med.-psychol. 1978; 136:549-561.

Arroll B. et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann . fam . Med . 2005; 3(5): 449-456.

Raisky V. A. Psychotropic drugs in the clinic of internal diseases. M.: Medicine; 1982.

Dovzhenko T.V., Maychuk E.Yu. Cardiac syndrome in cardiovascular diseases of various origins. Clinical: psychopathological, therapeutic aspects. Rus. honey. magazine 2001; 9 (25 b): 1192-1196.

Ariyo AA em al . Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000; 102: 1773-1779.

Jiang W., Davidson JR Antidepressant therapy in patients with ischemic heart disease. Durham , NC: Duke University Medical Center ; 2007..

Downloads

Published

2022-05-31

How to Cite

Alisher, B. (2022). THE ROLE OF ANTIDEPRESSANTS IN CARDIOLOGY PRACTICE. Modern Journal of Social Sciences and Humanities, 1(4), 551–557. https://doi.org/10.51699/mjssh.v1i4.192

Issue

Section

Articles